Index of reports
> Cases with DRY Mouth (5)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Transderm Scop (Scopolamine Transdermal) where reactions include dry mouth. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Transderm Scop side effects in 45 year old female
Reported by a consumer/non-health professional from United States on 2012-06-08
Patient: 45 year old female, weighing 56.2 kg (123.7 pounds)
Reactions: Mydriasis, DRY Mouth, Vision Blurred, Drug Withdrawal Syndrome
Drug(s) suspected as cause:
Transderm Scop
Possible Transderm Scop side effects in 58 year old female
Reported by a consumer/non-health professional from United States on 2012-05-14
Patient: 58 year old female, weighing 59.0 kg (129.7 pounds)
Reactions: Nausea, DRY Mouth, DRY Throat
Drug(s) suspected as cause:
Transderm Scop
Possible Transderm Scop side effects in
Reported by a physician from United States on 2011-11-07
Patient:
Reactions: Mydriasis, Nausea, Suicidal Ideation, Anxiety, Panic Attack, DRY Mouth, Vision Blurred, Dizziness
Drug(s) suspected as cause:
Transderm Scop
Possible Transderm Scop side effects in 28 year old female
Reported by a consumer/non-health professional from United States on 2011-10-21
Patient: 28 year old female, weighing 65.8 kg (144.7 pounds)
Reactions: Confusional State, Impaired Work Ability, Fear, Hyperhidrosis, Palpitations, DRY Mouth, Photophobia, Heart Rate Irregular, Hyperacusis, Condition Aggravated, Application Site Pain, Irritability, Therapeutic Response Decreased, Hyperaesthesia, Panic Attack, Insomnia, Vertigo, Withdrawal Syndrome, Feeling Abnormal, Application Site Irritation
Drug(s) suspected as cause:
Transderm Scop
Possible Transderm Scop side effects in 86 year old female
Reported by a consumer/non-health professional from United States on 2011-10-18
Patient: 86 year old female
Reactions: Off Label Use, Vomiting, DRY Mouth, Condition Aggravated, Disorientation, Amnesia
Drug(s) suspected as cause:
Transderm Scop
Dosage: 1 df, q72h
Indication: Dizziness
Start date: 2011-01-01
Transderm Scop
Indication: Balance Disorder
Other drugs received by patient: Vitamin B-12; Atacand; Labetalol HCL; Levothyroxine Sodium
|